Board of Directors

Members of the Board of Directors are appointed by the Minister for Health and are responsible for setting the strategic direction of the service, appointing the Chief Executive Officer and overseeing the management of the service.

Powers and duties of the Board

Monash Health is a public health service pursuant to the Health Services Act 1988 (Vic) and:

  • is a body corporate with perpetual succession
  • may sue and be sued in its corporate name
  • is capable of purchasing, taking, holding, selling, leasing, taking on lease, exchanging and disposing of real and personal property
  • is capable of doing and suffering all acts and things which bodies corporate may by law do or suffer, and
  • the board has such powers as are necessary to enable it to carry out its function, including the power to make, amend or revoke by-laws.

The functions of the Board of Directors are:

  • to establish the objectives of the hospital
  • to establish the organisational structure of the hospital
  • to appoint a person to fill a vacancy in the position of Chief Executive Officer
  • to oversee the management of the hospital by the Chief Executive Officer
  • to develop plans, strategies and budgets to ensure the provision of health services by the hospital and the long term financial viability of the hospital
  • to monitor the performance of the hospital, and
  • to monitor the performance of the Chief Executive Officer of the hospital.

Board of Directors

Mr Dipak Sanghvi

Mr Dipak Sanghvi

BSc Pharm (UK), FAICD, FAIPM

Chair of the Monash Health Board
Chair, Remuneration Committee
Chair, Aboriginal Health Strategic Partnership Committee
Member, Community Advisory Committee

Term of appointment: December 2015 – current

Mr Dipak Sanghvi is a pharmacist who owns five pharmacies in Victoria. He is currently Chair of Member Benefits Australia Pty Ltd. Previous positions held include President of the Pharmacy Guild Victoria Branch from 2006 to 2011, Chair of Gold Cross Products and Services Pty Ltd, Chair of Return of Unwanted Medicines, Board member of Guild Insurance and Superannuation and of Meridian Lawyers, as well as several other board positions in the community and pharmaceutical industry. He is also currently Chair of Musculoskeletal Australia.

Ms Aurelia Balpe

Ms Aurélia Balpe

MBA, GAICD, GradDip Demog, BEc, GradDip Psych

Chair, Primary Care and Population Health Advisory Committee
Member, Finance Committee

Term of appointment: July 2018 – current

Ms Aurélia Balpe is an international humanitarian leader with experience in the non-profit and for-profit sectors in Asia, the Pacific, the Americas, Africa and Europe. Ms Balpe has worked with boards and senior executive teams on the development of strategy and policy, legal compliance, risk management, organisational performance and the resolution of integrity issues. Ms Balpe has had oversight of multinational programs in organisational development, disaster response and law, water and sanitation and health. Ms Balpe has been a strategic advisor to governments, United Nations agencies, regional organisations and corporations on humanitarian action and coordination. Ms Balpe currently serves as a member of the Australian Red Cross Divisional Advisory Board. In 2015 she was awarded the Vanuatu Red Cross medal for her contribution to the Tropical Cyclone Pam Relief Operation. In 2017 she was the recipient of the Monash University Top Achievement and Dean’s Awards for her MBA.

Mrs Jane Bell

Mrs Jane Bell

BEc, LLB, LLM (Lond), FAICD

Chair, Audit Committee
Member, Remuneration Committee
Director, Kitaya Holdings Pty Ltd*
Member, Audit Committee, Kitaya Holdings Pty Ltd*

Term of appointment: July 2018 – current

Mrs Jane Bell is a banking and finance lawyer and non-executive director with more than 30 years’ experience in leading law firms, financial services, corporate treasury operations and governance gained living in Melbourne, London, Toronto, San Francisco and Brisbane. Mrs Bell has been a non-executive director since 2002, serving on 11 boards including eight health sector and medical research institute boards. Mrs Bell currently serves as Deputy Chair of Biomedical Research Victoria, Director of UCA Funds Management Limited and as Chair of the Community Advisory Group of the Melbourne Genomics Health Alliance. Mrs Bell is a Member of the Administrative Appeals Tribunal. She is a former Board member of Melbourne Health (Royal Melbourne Hospital), WorkSafe Victoria, Hudson Institute of Medical Research-Monash Institute of Medical Research-Prince Henry’s Institute of Medical Research, Queensland Institute of Medical Research Trust, Victorian Women’s Housing Association, Australian Red Cross (Qld) and Deputy Chair of Westernport Water Corporation.

*Kitaya Holdings Pty Ltd operates Jessie McPherson Private Hospital

Mr Tony Brain

Mr Tony Brain

BCom, CA, FAIST, GAICD

Chair, Finance Committee
Member, Audit Committee
Member, Remuneration Committee

Term of appointment: July 2019 – current

Mr Tony Brain is a Chartered Accountant with over 30 years’ experience in governance, assurance, finance and regulatory oversight. His executive leadership experience includes 12 years as Partner at Deloitte and nearly three years as Head of Risk Management at AustralianSuper. In addition to Monash Health, his current non-executive director experience includes three years at the Australian Scholarships Group Friendly Society Pty Ltd and nearly one year at AMP Superannuation Limited where he is currently Interim Chair. Mr Brain also sits on Board Committees for Victoria University, Barwon Health, Magistrates Court Victoria and the Alannah and Madeline Foundation. He is a current member of the Companies Auditor Disciplinary Board.

Ms Helen Brunt

Ms Helen Brunt

BA (Hons), GAICD

Member, Audit Committee
Member, Finance Committee

Term of appointment: July 2019 – current

Ms Brunt is a senior governance and technology delivery executive who brings extensive experience in digital technology and largescale transformation in complex business environments including Wesfarmers and Westpac. She is skilled in developing strategies to leverage technology to support business strategy. Ms Brunt is passionate about diversity and the use of technology to transform customer and employees experience and previously served as an associate board member for the VIC ICT for Women in IT. She has previously served as an elected Member Director of the Wesfarmers Super Trust Policy Committee.

Dr Misty Jenkins

Associate Professor Misty Jenkins

BSc (Hons), PhD, MAICD

Member, Quality Committee
Member, Aboriginal Health Strategic Partnership Committee

Term of appointment: November 2016 – current

Associate Professor Misty Jenkins is an NHMRC fellow, biomedical scientist and laboratory head at Walter and Eliza Hall Institute for Medical Research, where she researches cellular immunology and new immunotherapies for cancer. Ms Jenkins has previously held postdoctoral positions at the Universities of Cambridge and Oxford, and The Peter MacCallum Cancer Centre in Melbourne. Ms Jenkins was awarded the L’Oreal for Women in Science Fellowship (2013), was Tall Poppy of the Year (2015) and won the Westpac/Australian Financial Review 100 Women of Influence award (2016).In addition to her research career, Ms Jenkins brings experience in governance as a Director and Deputy Chair of The National Centre for Indigenous Genomics at ANU, as a former Director of the Aurora Education Foundation, Ambassador for the Poche Centre for Indigenous Health and Chair of NHMRC Project Grant Review Panels.

Professor Peter McDougall

MB, BS, FRACP, MBA, GAICD

Member, Quality Committee
Member, Primary Care and Population Health Advisory Committee
Term of appointment: 1 July 2020 – current

Peter McDougall trained in paediatrics as a neonatologist at the Royal Children’s Hospital, Melbourne and the Bristol Maternity Hospital, UK before starting his consultant career in newborn medicine at the Royal North Shore Hospital of Sydney. He returned to the Royal Children’s Hospital in 1984. In 1998, after completing his MBA, he was appointed Director, Division of Medicine and Head of Neonatology at the Royal Children’s Hospital and was made Chief of Medicine in 2005. In 2010, he was appointed Executive Director of Medical Services and Clinical Governance at the Royal Children’s Hospital. With Associate Professor David Armstrong, he served as the Co-Clinical Lead of the Victorian Paediatric Clinical Network, Safer Care Victoria from 2014-2018. He was appointed Honorary Clinical Professor with the University of Melbourne Department of Paediatrics in 2015.

Peter has had a long commitment to quality and safety in hospital services, including: Chairing the inaugural Patient Safety Committee at the Royal Children’s Hospital from 1998-2016; membership of the Consultative Council on Obstetric and Paediatric Mortality and Morbidity from 1991-2018; and Director of Clinical Governance at the Royal Children’s Hospital.

Since leaving the Royal Children’s Hospital, he has: served as a senior clinical advisor to the Consultative Council on Obstetric and Paediatric Mortality and Morbidity; conducted ad hoc reviews of hospital services; and been a member of the Steering Committee of the NSW Review of Health Services for Children and Young People in the NSW Health System.

Robyn McLeod

Ms Robyn McLeod

BA, BEd, GAICD

Member, Community Advisory Committee
Member, Finance Committee

Term of appointment: July 2019 – current

Ms Robyn McLeod is a governance and public policy expert who currently serves on the Boards of Melbourne Water and VicWater, and previously served as a member of the Governance working group of the Board of Good Shepherd Australia and New Zealand. Her previous positions include director of the Australian Centre for Social Innovation, Independent Commissioner for Water Security in South Australia, National Director of Water for KPMG, Executive Director of Major Projects Water with the Department of Sustainability and Environment, Victoria and Chief of Staff to the Victorian Energy Resources and Ports Minister.

Emeritus Professor Hatem Salem AM

Emeritus Professor Hatem Salem AM

AMMB, ChB (Mosul, Iraq), FRACP, FRCPA, MRCP, MD (Monash), LRCP, MRCS

Chair, Quality Committee
Member, Remuneration Committee
Term of appointment: May 2017 – current

Professor Hatem Salem is an Emeritus Professor at Monash University. Prior to this, Professor Salem was the Head of the Academic Department of Clinical Haematology at Monash University and the Head of Clinical Haematology at the Alfred Hospital. He served as President of the Asia Pacific Society of Thrombosis and Haemostasis and past President and Executive Director of the Australasian Society of Thrombosis and Hemostasis. He is a senior Counsellor of the International Society of Thrombosis and Haemostasis. In 2005, his vision and ability to develop leading clinical and research programs was recognised by the Victorian Government’s Public Healthcare Award, where he was the recipient of the Health Minister’s Award for Outstanding Individual Achievement. In 2010, Professor Salem was awarded a Member of the Order of Australia (AM) for service to medicine in the fi eld of haematology as a clinician, educator and researcher and also through the establishment of the Australian Centre for Blood Diseases.

Get the latest information about coronavirus (COVID-19).Find out more
+